Related Experiment Videos
[Pediatric laryngeal papillomatosis: our experience (three cases)]
O Rodrigo Chiner1, J Gisbert Aguilar, M D Sánchez Alcón
1Servicio de ORL, Hospital, Universitario La Fe, Valencia.
Acta Otorrinolaringologica Espanola
|September 1, 1995
Summary
Juvenile laryngeal papillomatosis cases were treated with surgical excision and alpha interferon. Two patients achieved long-term remission, while one continues interferon therapy, showing potential for managing this airway obstruction condition.
Area of Science:
- Otolaryngology
- Pediatric Surgery
- Viral Infections
Background:
- Juvenile laryngeal papillomatosis (JLP) is a rare condition caused by human papillomavirus (HPV).
- Upper airway obstruction is a primary concern in JLP, necessitating prompt intervention.
- Surgical excision is the standard treatment for papilloma removal.
Observation:
- This study reports on three cases of JLP treated between 1984 and 1994.
- All patients underwent surgical excision to address airway obstruction.
- Two patients received alpha interferon as an adjunct to surgical treatment.
Findings:
- Two of the three patients achieved long-term remission and are asymptomatic.
- One patient remains under treatment with alpha interferon.
- Surgical debulking combined with interferon therapy demonstrated positive outcomes in managing JLP.
Implications:
- Early and aggressive management of JLP is crucial for preventing severe airway compromise.
- Alpha interferon may serve as an effective adjunctive therapy for recalcitrant JLP.
- Further research into long-term efficacy and optimal treatment protocols for JLP is warranted.